2. UroToday Home
  3. Video Lectures

APCCC 2022 Videos

Navigating the Future of Prostate Cancer Treatment and Global Access at APCCC 2024 - Silke Gillessen
June 14, 2023
Details
PSMA PET Imaging Hot Topics - Neal Shore & Jason Efstathiou
November 4, 2022
Details
A Urologist's Perspective on PSMA-Radioligand Therapy in the Treatment Setting of mCRPC - Neal Shore
October 17, 2022
Details
Lutetium-617 - Treatment Sequencing Considerations for Metastatic Castration-Resistant Prostate Cancer - Neal Shore
October 16, 2022
Details
APCCC 2022: First-Line Therapy for Metastatic Castration-Resistant Prostate Cancer - Evan Yu
October 16, 2022
Details
Cancer Survivorship and PCF - Matthew Smith & Alicia Morgans
October 16, 2022
Details
Immune Checkpoint B7-H3 - APCCC 2022 - Emmanuel Antonarakis
October 16, 2022
Details
Optimal Sequencing - Should It Include Radium Given Lutetium? - Joe O'Sullivan
October 16, 2022
Details
Genomic and Clinical Markers in nmCRPC APCCC 2022 Presentation - Joaquin Mateo
October 12, 2022
Details
How To Interpret and Confirm Lesions Positive on PSMA PET but With No Correlation on CT? APCCC 2022 Presentation - Stefano Fanti
October 11, 2022
Details
Does “Oligoprogressive” Prostate Cancer Exist as a Distinct Clinically Meaningful Entity and if Yes, How To Treat It? APCCC 2022 Presentation - Robert Jones
October 11, 2022
Details
From ADT to Triplet Therapy: Rethinking Treatment Paradigms in Metastatic Hormone Sensitive Prostate Cancer - Matthew Smith & Kim Chi
September 27, 2022
Details
What is the Evidence of MDT in Synchronous vs Metachronous mHSPC? APCCC 2022 Presentation - Daniel Spratt
September 22, 2022
Details
Are There Predictors for Successful Treatment of Oligometastatic Prostate Cancer? APCCC 2022 Presentation - Piet Ost
September 22, 2022
Details
Treatment of Vulnerable/Frail Patients with mHSPC APCCC 2022 Presentation - Alicia Morgans
September 21, 2022
Details
What Is the Evidence of Systemic Therapies (Alone or in Combination With MDT) in Oligometastatic mHSPC? APCCC 2022 Presentation - Mary Ellen Taplin
September 21, 2022
Details
Impact of Histology Variants (Ductal/Intraductal/Cribriform) on Treatment Recommendation Presentation - Declan Murphy
September 21, 2022
Details
Update on Immune Checkpoint Inhibitors APCCC 2022 Presentation - Emmanuel Antonarakis
September 21, 2022
Details
Optimal Treatment for mHSPC from a Health Economics Standpoint APCCC 2022 Presentation - Caroline Clarke
September 21, 2022
Details
Aggressive Variant Prostate Cancer: Definition, Diagnosis, Treatment APCCC 2022 Presentation - Eric Small
September 18, 2022
Details
Debate: PARP Inhibitors for All mCRPC Patients APCCC 2022 Presentation - Noel Clarke
September 15, 2022
Details
Importance of Lifestyle and Prevention of Complications in Advanced Prostate Cancer: How to Take Care of Muscle Strength? APCCC 2022 Presentation - Heather Cheng
September 15, 2022
Details
Risk-Adapted Treatment Monitoring in mCRPC APCCC 2022 Presentation - Anwar Padhani
September 14, 2022
Details
Is There Still a Role for Radium-223? APCCC 2022 Presentation - Neal Shore
September 14, 2022
Details
Can Biology Help Inform Treatment Decisions In the Management of mHSPC? APCCC 2022 Presentation - Gert Attard
September 11, 2022
Details
When Low-Volume on Conventional Imaging Goes into High-Volume on Next-Generation Imaging in mHSPC - Treat like High-Volume APCCC 2022 Presentation - Ian Davis
September 5, 2022
Details
Importance of Lifestyle and Prevention of Complications in Advanced Prostate Cancer: How to Take Care of the Bones? APCCC 2022 Presentation - Oliver Sartor
September 1, 2022
Details
How To Read a Genomic Testing Report APCCC 2022 Presentation - Kim Chi
September 1, 2022
Details
Lutetium-PSMA Therapy APCCC 2022 Presentation - Matthew Smith
August 29, 2022
Details
Optimal Treatment Sequencing in mCRPC APCCC 2022 Presentation - Maha Hussain
August 29, 2022
Details
Emerging Therapies and Therapeutic Targets in Prostate Cancer - Mark Rubin
August 28, 2022
Details
Treating Metastatic Castration-Resistant Prostate Cancer Session Discussion APCCC 2022 Presentation - Silke Gillessen
August 25, 2022
Details
Treatment De-escalation Strategies in mHSPC APCCC 2022 Presentation - Bertrand Tombal
August 23, 2022
Details
Treatment Intensification Strategies in mHSPC: Triplets and More APCCC 2022 Presentation - Christopher Sweeney
August 23, 2022
Details
When Low-Volume on Conventional Imaging Goes Into High-Volume on Next-Generation Imaging in mHSPC - Treat like Low-Volume APCCC 2022 Presentation - Karim Fizazi
August 22, 2022
Details
When Low-Volume on Conventional Imaging Goes into High-Volume on Next-Generation Imaging in mHSPC - How Frequent Is This Situation? APCCC 2022 Presentation - Michael Hofman
August 22, 2022
Details
The Uptake of New Treatment Options for mHSPC in Real Life -- Education, Access, Use, and Diversity APCCC 2022 Presentation - Andrew Armstrong
August 22, 2022
Details
Ironman Registry: Pioneering Data Collection and Biomarker Analysis in Prostate Cancer Research Daniel George
August 19, 2022
Details
Debate: PARP Inhibitors Only in Selected mCRPC Patients APCCC 2022 Presentation - Johann de Bono
August 18, 2022
Details
Importance of Lifestyle and Prevention of Complications in Advanced Prostate Cancer: How to Take Care of Brain and Mood? Presentation APCCC 2022 - Charles Ryan
August 16, 2022
Details
Management of pN1 Prostate Cancer (Including Systemic Therapy) APCCC 2022 Presentation - Derya Tilki
August 14, 2022
Details
Disadvantages of Using Novel Imaging in nmCRPC APCCC 2022 Presentation - Alberto Briganti
August 11, 2022
Details
Advantages of Using Novel Imaging in nmCRPC APCCC 2022 Presentation - Michael Morris
August 11, 2022
Details
M0 CPRC: Overview of Treatment Options APCCC 2022 Presentation - Eleni Efstathiou
August 11, 2022
Details
Importance of Lifestyle and Prevention of Complications in Advanced Prostate Cancer: How to Take Care of the Heart? APCCC 2022 Presentation - Fred Saad
August 11, 2022
Details
Biochemical Recurrence After Definitive Radiotherapy of the Prostate – What Are the Local Treatment Options? APCCC 2022 Presentation - Jochen Walz
August 11, 2022
Details
Who Needs Systemic Treatment With Salvage Radiotherapy? APCCC 2022 Presentation - Brandon Mahal
August 11, 2022
Details
How Can Treatment Be Individualized By Using Genomic Classifiers? APCCC 2022 Presentation - Felix Feng
August 11, 2022
Details
PSA Directed Treatment for BCR APCCC 2022 Presentation - Neha Vapiwala
July 29, 2022
Details
Imaging Directed Treatment for Biochemical Recurrence APCCC 2022 Presentation - Nicholas James
August 11, 2022
Details
Who Needs Early Salvage RT and Who Needs Adjuvant RT in 2022? APCCC 2022 Presentation - Kosj Yamoah
August 10, 2022
Details
Management of Clinical N1 Prostate Cancer (Including Systemic Therapy) APCCC 2022 Presentation - Darren Poon
August 10, 2022
Details
Are We Ready to Change Management Based on Next-Generation Imaging? No APCCC 2022 Presentation - Nicolas Mottet
August 10, 2022
Details
Are We Ready to Change Management Based on Next-Generation Imaging? YES: APCCC 2022 Presentation - Jason Efstathiou
August 9, 2022
Details
Who Needs Early Salvage Radiotherapy and Who Needs Adjuvant Radiotherapy in 2022? - Kosj Yamoah
July 19, 2022
Details
Incorporating Molecular Testing into Clinical Practice for Prostate Cancer - Elena Castro & Colin Pritchard
July 4, 2022
Details
Depression, Bone Health and Exercise in Prostate Cancer - Fred Saad, Tomasz Beer & Charles Ryan
June 27, 2022
Details
De-escalation Treatment Strategies in Metastatic Hormone-Sensitive Prostate Cancer - Bertrand Tombal
June 24, 2022
Details
When Low-Volume on Conventional Imaging Goes Into High-Volume on Next-Generation Imaging in mHSPC - Karim Fizazi
June 19, 2022
Details
The Use of PARP Inhibitors in Castrate-Resistant Prostate Cancer - Elena Castro & Joaquin Mateo
June 19, 2022
Details
PARPi Combination Therapy Use in Clinical Practice - Ready for Prime-Time? - Maha Hussain and Fred Saad
June 8, 2022
Details
Closing Remarks from the 2022 Advanced Prostate Cancer Consensus Conference (APCCC 2022) - Silke Gillessen, Aurelius Omlin, Neal Shore, Charles Ryan & Alicia Morgans
May 24, 2022
Details
Systemic Treatment in the Context of Salvage Radiation and Biochemical Recurrence - Piet Ost
May 18, 2022
Details
The Conundrum of Systemic Salvage Therapy at the Time of Salvage Radiation Therapy - Brandon Mahal
May 18, 2022
Details
Demystifying PSMA Theranostics: A Discussion on Implementing Lutetium-177 Treatment - Oliver Sartor
May 2, 2022
Details
Beyond Clinical Trials: Mastering Patient Care for Lutetium-PSMA-617 Therapy - Michael Morris
May 2, 2022
Details
Looking Forward to the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 - Aurelius Omlin
April 7, 2022
Details
The APCCC 2022 - A Hybrid Meeting April 28 - 30 - Silke Gillessen
April 3, 2022
Details